HLB Pharmaceutical Co. Ltd Cash Flow Quality Index
HLB Pharmaceutical Co. Ltd cash flow quality index. HLB Pharmaceutical Co. Ltd (047920) has a Cash Flow Quality Index of -0.68x as of March 2025. Operating cash flow of ₩-1.07 Billion is below net income of ₩1.57 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore HLB Pharmaceutical Co. Ltd (047920) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of HLB Pharmaceutical Co. Ltd (2014–2024)
Cash flow quality index of HLB Pharmaceutical Co. Ltd from 2014 to 2024. Historical Cash Flow Quality Index for HLB Pharmaceutical Co. Ltd across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. See debt-free asset ratio of HLB Pharmaceutical Co. Ltd to measure how much of total assets are equity-financed.
HLB Pharmaceutical Co. Ltd Cash Flow Quality Index by Year (2014–2024)
HLB Pharmaceutical Co. Ltd cash flow quality index by year from 2014 to 2024. Year-by-year earnings quality comparison for HLB Pharmaceutical Co. Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of HLB Pharmaceutical Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 3.39x | ₩6.84 Billion | ₩2.02 Billion | ▲ +18.3% |
| 2019 | 2.86x | ₩1.35 Billion | ₩472.66 Million | ▲ +875.8% |
| 2016 | -0.37x | ₩-213.11 Million | ₩577.41 Million | ▼ -107.3% |
| 2014 | 5.06x | ₩1.54 Billion | ₩304.58 Million | — |